Chronic granulomatous disease

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

10 events
Mar 2026Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

Paul Szabolcs — PHASE2

TrialRECRUITING
Sep 2025Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease

National Institute of Allergy and Infectious Diseases (NIAID) — PHASE1

TrialENROLLING BY INVITATION
Aug 2025Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease

Ensoma — PHASE1, PHASE2

TrialRECRUITING
Nov 2024Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

Ensoma

TrialRECRUITING
Oct 2024A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )

Prime Medicine, Inc. — PHASE1, PHASE2

TrialACTIVE NOT RECRUITING
Jun 2024pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)

National Institute of Allergy and Infectious Diseases (NIAID) — PHASE1, PHASE2

TrialENROLLING BY INVITATION
Apr 2024Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease

National Institute of Allergy and Infectious Diseases (NIAID) — PHASE1

TrialRECRUITING
Mar 2023Lentiviral Gene Therapy for p47 AR-CGD

Great Ormond Street Hospital for Children NHS Foundation Trust — PHASE1, PHASE2

TrialRECRUITING
Jan 2023Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)

National Institute of Allergy and Infectious Diseases (NIAID) — EARLY_PHASE1

TrialACTIVE NOT RECRUITING
Aug 2022Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications

National Institute of Allergy and Infectious Diseases (NIAID) — PHASE1, PHASE2

TrialENROLLING BY INVITATION

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Chronic granulomatous disease.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Actimmune

(Interferon gamma 1-b)Orphan drug

Horizon Therapeutic Ireland DAC

Interferon gamma [EPC]

12.1 Mechanism of Action Interferons bind to specific cell surface receptors and initiate a sequence of intracellular events that lead to the transcri...

Approved Dec 1990FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

20 active trials
2Phase 2
3Phase 1
2N/A
2Unknown
2EARLY_PHASE1
9PHASE1, PHASE2
20Total recruiting
Search clinical trials for Chronic granulomatous disease

Recent News & Research

No recent news articles indexed yet for Chronic granulomatous disease.
Search PubMed for Chronic granulomatous disease

Browse all Chronic granulomatous disease news →

Specialist Network

Top 6 by expertise

View all Chronic granulomatous disease specialists →

Quick Actions